KC7F2 has been shown to prevent the activation of HIF-target genes such as the upregulation of fibronectin and MMP-2 and the suppression of E-cadherin and tissue inhibitor of metalloproteinases-2 in human liver cancer cells43, which is in line with our in vitro findings in VSMC. Here, TIMP2 is linked to liver cancer.